Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2027
Grand Nikko Tokyo DaibaTokyo

Chris Oswald
Founder, Owner, and Principal Consultant at Coswald Consulting LLC
Speaker

Profile

Chris is an independent consultant specializing in CMC related activities. His experience spans from developing oligo related analytical methods in the laboratory, to managing a commercial QC laboratory, and then into being the manufacturing plant manager for Agilent Technologies. These roles have provided him exposure to many CMC strategies that have been successfully utilized for clinical, pre-commercial, and commercial oligonucleotides in both the drug substance and drug product arenas. Chris also has a wide range of experience in facility buildouts, both new and appended, allowing exposure and understanding of the many unseen, as well as the very visible, parameters related to facility, equipment, process, and personnel that are necessary to align and control to ensure a successful and robust scaleup / technical transfer.

Agenda Sessions

  • Manufacturing and Upscale Challenges of Next-generation Oligonucleotide Therapeutics

    9:10am